J2252
HCPCSInj midazolam in 0.8% nacl
Official HCPCS Level II long descriptor
Injection, midazolam in 0.8% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg
HCPCS Level II code J2252 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj midazolam in 0.8% nacl
Added to HCPCS: 2024-10-01
Nearby codes in J2
- J2210Methylergonovin maleate inj
- J2212Methylnaltrexone injection
- J2246Inj, micafungin (baxter)
- J2247Inj, micafungin (par pharm)
- J2248Micafungin sodium injection
- J2249Inj, remimazolam, 1 mg
- J2250Inj midazolam hydrochloride
- J2251Inj midazolam in 0.9% nacl
- J2253Inj midazolam (seizalam)
- J2260Inj milrinone lactate / 5 mg
- J2265Minocycline hydrochloride
- J2267Inj, mirikizumab-mrkz, 1 mg
- J2270Morphine sulfate injection
- J2272Inj, morphine (fresenius)
- J2274Inj morphine pf epid ithc
- J2277Inj, motixafortide, 0.25 mg
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.